Inhibitory effect of tumor suppressor Pdcd4 on tumor malignancy.
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-A-049-Tuesday
- By: KINOSHITA, Eriko (School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University, Department of Pharmacology I, Hyogo, Japan)
- Co-author(s): Eriko Kinoshita: Department of Pharmacology I, School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University, Nishinomiya, Japan
Noriko Yoshikawa: Department of Pharmacology I, School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University, Nishinomiya, Japan
Yuka Inoue: Department of Pharmacology I, School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University, Nishinomiya, Japan
Sachiko Kita: Department of Pharmacology I, School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University, Nishinomiya, Japan
Chihiro Kuribayashi: Department of Pharmacology I, School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University, Nishinomiya, Japan
Mayuko Hatai: Department of Pharmacology I, School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University, Nishinomiya, Japan
Satomi Kagota: Department of Pharmacology Ⅱ, School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University, Nishinomiya, Japan
Kazumasa Shinozuka: Department of Pharmacology Ⅱ, School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University, Nishinomiya, Japan
Kazuki Nakamura: Department of Pharmacology I, School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University, Nishinomiya, Japan - Abstract:
Backgrounds
Programmed cell death 4 (Pdcd4) is a novel tumor suppressor gene which acts as a negative regulator of protein translation and malignant transformation. However, the direct targets of Pdcd4 have not been clarified. We report the presence of a negative correlation between the metastatic ability of tumor cells and expression levels of.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023